Antibody data
- Antibody Data
 - Antigen structure
 - References [2]
 - Comments [0]
 - Validations [0]
 
Submit
Validation data
Reference
Comment
Report error
- Product number
 - GTX21107 - Provider product page

 - Provider
 - GeneTex
 - Proper citation
 - GeneTex Cat#GTX21107, RRID:AB_368764
 - Product name
 - CA125 antibody [X75]
 - Antibody type
 - Monoclonal
 - Reactivity
 - Human
 - Host
 - Mouse
 
Submitted references		Lymphokine-activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascites.
				
Human tumour immune evasion via TGF-β blocks NK cell activation but not survival allowing therapeutic restoration of anti-tumour activity.
				
		
	
			Jennings VA, Ilett EJ, Scott KJ, West EJ, Vile R, Pandha H, Harrington K, Young A, Hall GD, Coffey M, Selby P, Errington-Mais F, Melcher AA
International journal of cancer 2014 Mar 1;134(5):1091-101
		International journal of cancer 2014 Mar 1;134(5):1091-101
Human tumour immune evasion via TGF-β blocks NK cell activation but not survival allowing therapeutic restoration of anti-tumour activity.
			Wilson EB, El-Jawhari JJ, Neilson AL, Hall GD, Melcher AA, Meade JL, Cook GP
PloS one 2011;6(9):e22842
		PloS one 2011;6(9):e22842
				No comments: Submit comment	
	
			
			No validations: Submit validation data